Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2009;54:775-781
Published online before print August 3, 2009, doi: 10.1161/HYPERTENSIONAHA.109.133538
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
54/4/775    most recent
HYPERTENSIONAHA.109.133538v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Geeganage, C. M.
Right arrow Articles by Bath, P. M.W.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geeganage, C. M.
Right arrow Articles by Bath, P. M.W.
Related Collections
Right arrow Cerebrovascular disease/stroke
Right arrow Clinical Studies
Right arrow Acute Cerebral Hemorrhage
Right arrow Acute Cerebral Infarction
Right arrowRelated Article

(Hypertension. 2009;54:775.)
© 2009 American Heart Association, Inc.


Original Articles

Relationship Between Therapeutic Changes in Blood Pressure and Outcomes in Acute Stroke

A Metaregression

Chamila M. Geeganage; Philip M.W. Bath

From the Stroke Trials Unit, University of Nottingham, Nottingham, United Kingdom.

Correspondence to Philip M.W. Bath, Division of Stroke Medicine, University of Nottingham, Nottingham City Campus, Nottingham NG5 1PB, United Kingdom. E-mail philip.bath{at}nottingham.ac.uk

Both low and high blood pressures (BPs) during the acute phase of stroke are associated independently with a poor outcome. Several small clinical trials have involved the alteration of BP, and this study assessed the relationship between change in BP and functional outcome. Randomized, controlled trials of interventions that would be expected, on pharmacological grounds, to alter BP in patients within 1 week of the onset of acute ischemic or hemorrhagic stroke were sought using electronic searches. Data were collected on BP and clinical outcome. The relationship between the differences in on-treatment BP and odds ratios for outcomes was assessed using meta-regression. Thirty-seven trials involving 9008 patients were included. A U- or J-shaped relationship was found among on-treatment BP difference and early death, death at the end of 90-day follow-up, and combined death or dependency at the end of follow-up. Although outcomes were not significantly reduced at any level of change in BP, the lowest odds occurred at the following times: early death (odds ratio: 0.87; 95% CI: 0.54 to 1.23), 8.1 mm Hg; death at the end of follow-up (odds-ratio: 0.96; 95% CI: 0.31 to 1.65), 14.4 mm Hg; and combined death or dependency at the end of follow-up (odds ratio: 0.95; 95% CI: 0.11 to 1.72), 14.6 mm Hg. Although large falls or increases in BP are associated with a worse outcome, modest reductions may reduce death and combine death or dependency, although the CIs are wide and compatible with an overall benefit or hazard.


Key Words: acute stroke • blood pressure • metaregression • randomized, controlled trial


Related Article:

Treating Hypertension in Acute Ischemic Stroke
J. David Spence
Hypertension 2009 54: 702-703. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
HypertensionHome page
J. D. Spence
Treating Hypertension in Acute Ischemic Stroke
Hypertension, October 1, 2009; 54(4): 702 - 703.
[Full Text] [PDF]